检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Phase 2 safety and efficacy results of TAK-228 in combination with exemestane or fulvestrant in postmenopausal women with ERpositive/HER2-negative metastatic breast cancer previously treated with everolimus

J. R. Diamond, D. Potter,M. Salkeni,P. Silverman,T. Haddad, F. Forget,A. Awada,J-L Canon,M. Danso,A. Lortholary,H. Bourgeois,E. Tan-Chiu, C. Patel,R. Neuwirth,E. J. Leonard,B. Lim

CANCER RESEARCH（2019）

引用 3|浏览37
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要